Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (2.348)

91

Presentation and outcomes of chronic kidney disease patients with COVID-19

enthalten in: Jornal brasileiro de nefrologia | 2022

von Branco, C. | Duarte, I. | Gameiro, J. | +8

92

Population pharmacokinetics of ethambutol in African children : a pooled analysis

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Tikiso, T. | McIlleron, H. | Abdelwahab, M. | +11

93

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

enthalten in: Antiviral research | 2022

von Foo, C. | Abdelnabi, R. | Kaptein, S. | +23

94

Revealing the toxicity of lopinavir- and ritonavir-containing water and wastewater treated by photo-induced processes to Danio rerio and Allivibrio fischeri

enthalten in: The Science of the total environment | 2022

von Czech, B. | Krzyszczak, A. | Boguszewska-Czubara, A. | +3

95

Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Ghosh, R. | Chakraborty, A. | Biswas, A. | +1

96

Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Heaton, B. | Jensen, R. | Line, J. | +4

97

Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease : a computational-aided approach

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Fadaka, A. | Aruleba, R. | Sibuyi, N. | +3

98

Off-Label Use of Hydroxychloroquine in COVID-19 : Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance

enthalten in: Journal of clinical pharmacology | 2022

von Fallani, E. | Cevenini, F. | Lazzerini, P. | +2

99

Safety profile of COVID-19 drugs in a real clinical setting

enthalten in: European journal of clinical pharmacology | 2022

von Chiu, M. | Bhardwaj, M. | Sah, S.

100

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729